|
|
Taiwan Academic Institutional Repository >
Browse by Title
|
Showing items 335106-335115 of 2348848 (234885 Page(s) Totally)
<< < 33506 33507 33508 33509 33510 33511 33512 33513 33514 33515 > >>
View [10|25|50] records per page
| 朝陽科技大學 |
2003 |
Discovery Customer Requirements By Using Three Tiers Text Categorization
|
嚴國慶; 王淑卿; 林佩樺; 魏家惠 |
| 中國醫藥大學 |
2007-12-04 |
Discovery for New Drugs to Activate AMP-activate protein kinase by Computer Aided Drug Design
|
(Jauo-Guei Yang); 陳語謙(Chen, Yu-Chian) |
| 臺大學術典藏 |
2018-09-10T08:41:17Z |
Discovery in Drell-Yan Processes at the LHC
|
Chiang, Cheng-Wei and Christensen, Neil D. and Ding, Gui-Jun and Han, Tao; CHENG-WEI CHIANG |
| 國立成功大學 |
2015-07 |
Discovery in Tainan Train Station
|
TSOI, Asta Waikwan |
| 佛光大學 |
2004-06-01 |
Discovery learning,representation, and explanation within a computer-based simulation: Finding the right mix
|
曾世綺;Rieber, L. P.;Tzeng, S. C.;Kelly, T. |
| 國家衛生研究院 |
2010-09 |
Discovery of 1-(2,4-Dichlorophenyl)-4-ethyl-5-(5-(2-(4-(trifluoromethyl)phenyl)ethynyl)thiophe n-2-yl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide as a potential peripheral cannabinoid-1 receptor inverse agonist
|
Hung, MS;Chang, CP;Li, TC;Yeh, TK;Song, JS;Lin, Y;Wu, CH;Kuo, PC;Amancha, PK;Wong, YC;Hsiao, WC;Chao, YS;Shia, KS |
| 國家衛生研究院 |
2013-11-13 |
Discovery of 1-(2,4-Dichlorophenyl)-N-(piperidin-1-yl)-4-((pyrrolidine-1-sulfonamido)methyl)-5 -(5-((4-(trifluoromethyl)phenyl)ethynyl)thiophene-2-yl)-1H-pyrazole-3-carboxamide as a novel peripherally restricted cannabinoid-1 receptor antagonist with significant weight-loss efficacy in diet-induced obese mice
|
Chang, CP;Wu, CH;Song, JS;Chou, MC;Wong, YC;Lin, Y;Yeh, TK;Sadani, AA;Ou, MH;Chen, KH;Chen, PH;Kuo, PC;Tseng, CT;Chang, KH;Tseng, SL;Chao, YS;Hung, MS;Shia, KS |
| 國家衛生研究院 |
2015-08 |
Discovery of 2,4-diaminopyrimidines bearing a unique pharmacophore as anaplastic lymphoma kinase inhibitors
|
Shiao, HY;Wang, WC;Hsu, YC;Ke, YY;Hsu, TA;Hsieh, HP |
| 國家衛生研究院 |
2009-07-23 |
Discovery of 2-[5-(4-chloro-phenyl)-1-(2,4-dichloro-phenyl)-4-ethyl-1H-pyrazol-3-yl]-1,5,5-trimethyl-1,5-dihydro-imidazol-4-thione (BPR-890) via an active metabolite. A novel, potent and selective cannabinoid-1 receptor inverse agonist with high antiobesity efficacy in DIO mice
|
Wu, CH;Hung, MS;Song, JS;Yeh, TK;Chou, MC;Chu, CM;Jan, JJ;Hsieh, MT;Tseng, SL;Chang, CP;Hsieh, WP;Lin, Y;Yeh, YN;Chung, WL;Kuo, CW;Lin, CY;Shy, HS;Chao, YS;Shia, KS |
| 中國醫藥大學 |
2010-01 |
Discovery of 3-(4-bromophenyl)-6-nitrobenzo[1.3.2]dithiazolium ylide 1,1-dioxide as a novel dual cyclooxygenase/5-lipoxygenase inhibitor that also inhibits tumor necrosis factor-a production
|
陳建樹(Chien-Shu Chen); (C.-M. Tan); (C.-H. Huang); (L.-C. Chang); (J.-P. Wang); (F.-C. Cheng); (J.-W. Chern)* |
Showing items 335106-335115 of 2348848 (234885 Page(s) Totally)
<< < 33506 33507 33508 33509 33510 33511 33512 33513 33514 33515 > >>
View [10|25|50] records per page
|
